ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/9/2026

1. AAPL
2. SPY
3. USO
4. IDYA
5. GILD
6. FDX
7. GLOO
8. SJM
9. KYMR
10. MTN

Go back to ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Update
(NASDAQ: ABVC) Delayed: 1.35 --0 (-0%)
Previous Close $1.35    52 Week High $25.00 
Open $1.35    52 Week Low $1.00 
Day High $1.35    P/E N/A 
Day Low $1.35    EPS $0.00 
Volume 2